These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Julkunen H, Ekblom-Kullberg S, Miettinen A. Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294 [Abstract] [Full Text] [Related]
4. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody. Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D. J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201 [Abstract] [Full Text] [Related]
5. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus. Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH. Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326 [Abstract] [Full Text] [Related]
6. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus. Metwally IM, Eesa NN, Yacoub MH, Elsman RM. Adv Rheumatol; 2019 Mar 04; 59(1):10. PubMed ID: 30832710 [Abstract] [Full Text] [Related]
7. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus. Zivković V, Stanković A, Cvetković T, Mitić B, Kostić S, Nedović J, Stamenković B. Srp Arh Celok Lek; 2014 Mar 04; 142(7-8):431-6. PubMed ID: 25233687 [Abstract] [Full Text] [Related]
11. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A. Arthritis Res Ther; 2009 Oct 14; 11(5):R154. PubMed ID: 19828047 [Abstract] [Full Text] [Related]
12. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Bruns A, Bläss S, Hausdorf G, Burmester GR, Hiepe F. Arthritis Rheum; 2000 Oct 14; 43(10):2307-15. PubMed ID: 11037891 [Abstract] [Full Text] [Related]
13. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy. Abdel Gawad ER, Mansour AI, Abdel Aziz YA, Soliman AF, Fawzy RM. Egypt J Immunol; 2014 Oct 14; 21(1):57-65. PubMed ID: 25204045 [Abstract] [Full Text] [Related]
15. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases. Půtová I, Dostal C, Becvar R. Ann N Y Acad Sci; 2007 Aug 14; 1109():275-86. PubMed ID: 17785316 [Abstract] [Full Text] [Related]
17. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis. Dieker J, Schlumberger W, McHugh N, Hamann P, van der Vlag J, Berden JH. Mol Immunol; 2015 Nov 14; 68(1):20-4. PubMed ID: 26597199 [Abstract] [Full Text] [Related]
18. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Pradhan VD, Patwardhan MM, Ghosh K. Indian J Dermatol Venereol Leprol; 2010 Nov 14; 76(2):145-9. PubMed ID: 20228543 [Abstract] [Full Text] [Related]
19. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Haugbro K, Nossent JC, Winkler T, Figenschau Y, Rekvig OP. Ann Rheum Dis; 2004 Apr 14; 63(4):386-94. PubMed ID: 15020332 [Abstract] [Full Text] [Related]
20. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari PF. J Autoimmun; 2004 May 14; 22(3):235-40. PubMed ID: 15041044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]